
Bank7 Corp. Fundamental Analysis (NASDAQ: BSVN)
Bank7 Corp. (NASDAQ: BSVN) shows moderate financial fundamentals with a PE ratio of 11.42, profit margin of 31.03%, and ROE of 16.48%. The company generates $0.1B in annual revenue with weak year-over-year growth of -3.87%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 64.3/100 based on profitability, valuation, growth, and balance sheet metrics. The C+ grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze BSVN's fundamental strength across five key dimensions:
Efficiency Score
WeakBSVN struggles to generate sufficient returns from assets.
Valuation Score
ExcellentBSVN trades at attractive valuation levels.
Growth Score
WeakBSVN faces weak or negative growth trends.
Financial Health Score
ExcellentBSVN maintains a strong and stable balance sheet.
Profitability Score
ExcellentBSVN achieves industry-leading margins.
Key Financial Metrics
Is BSVN Expensive or Cheap?
P/E Ratio
BSVN trades at 11.42 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, BSVN's PEG of -1.80 indicates potential undervaluation.
Price to Book
The market values Bank7 Corp. at 1.81 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 12.26 times EBITDA. This signals the market has high growth expectations.
How Well Does BSVN Make Money?
Net Profit Margin
For every $100 in sales, Bank7 Corp. keeps $31.03 as profit after all expenses.
Operating Margin
Core operations generate 41.46 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $16.48 in profit for every $100 of shareholder equity.
ROA
Bank7 Corp. generates $2.19 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Bank7 Corp. generates strong operating cash flow of $51.86M, reflecting robust business health.
Free Cash Flow
Bank7 Corp. generates strong free cash flow of $42.26M, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $4.44 in free cash annually.
FCF Yield
BSVN converts 8.80% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
11.42
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-1.80
vs 25 benchmark
P/B Ratio
Price to book value ratio
1.81
vs 25 benchmark
P/S Ratio
Price to sales ratio
3.56
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.00
vs 25 benchmark
Current Ratio
Current assets to current liabilities
324.44
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.16
vs 25 benchmark
ROA
Return on assets percentage
0.02
vs 25 benchmark
ROCE
Return on capital employed
0.03
vs 25 benchmark
How BSVN Stacks Against Its Sector Peers
| Metric | BSVN Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 11.42 | 21.12 | Better (Cheaper) |
| ROE | 16.48% | 655.00% | Weak |
| Net Margin | 31.03% | -778.00% (disorted) | Strong |
| Debt/Equity | 0.00 | 0.87 | Strong (Low Leverage) |
| Current Ratio | 324.44 | 871.99 | Strong Liquidity |
| ROA | 2.19% | 6590.00% | Weak |
BSVN outperforms its industry in 4 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Bank7 Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
147.93%
Industry Style: Value, Dividend, Cyclical
High GrowthEPS CAGR
122.00%
Industry Style: Value, Dividend, Cyclical
High GrowthFCF CAGR
81.56%
Industry Style: Value, Dividend, Cyclical
High Growth